1-4 of 4
Christina L. Kress
Close
Sort by
Journal Articles

Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer

Juan M. Zapata, David Llobet, Maryla Krajewska, Sophie Lefebvre, Christina L. Kress, John C. Reed
Journal: Blood
Blood (2009) 113 (19): 4595–4603.
https://doi.org/10.1182/blood-2008-07-165456
Published: 2009
Includes: Supplemental data
Journal Articles

Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2–transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)

Shinichi Kitada, Christina L. Kress, Maryla Krajewska, Lee Jia, Maurizio Pellecchia, John C. Reed
Journal: Blood
Blood (2008) 111 (6): 3211–3219.
https://doi.org/10.1182/blood-2007-09-113647
Published: 2008
Includes: Supplemental data
Journal Articles

Triterpenoids Display Single Agent Activity in a Mouse Model of CLL/SBL.

Christina L. Kress, BS, Marina Konopleva, Ph.D., Maryla Krajewska, M.D., Vanesa Martinez-Garcia, B.S., Sophie Lefebvre, Ph.D., Marc L. Hyer, Ph.D., Teresa McQueen, B.S., Michael Andreeff, Ph.D., John C. Reed, MD,Ph.D, Juan Zapata, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2530.
https://doi.org/10.1182/blood.V108.11.2530.2530
Published: 2006
Journal Articles

CDDO and CDDO-Im Reduce Tumor Burden in a Transgenic Mouse Model of CLL.

Juan M. Zapata, Ph.D., Christina L. Kress, BS, Marina Konopleva, Ph.D., Maryla Krajewska, M.D., Ph.D., Mark Hyer, Ph.D., Teresa McQueen, BS, Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3477.
https://doi.org/10.1182/blood.V104.11.3477.3477
Published: 2004